Document Detail


Electrocardiographic changes after dipyridamole infusion in patients undergoing myocardial perfusion imaging.
MedLine Citation:
PMID:  20145578     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Although the diagnostic and prognostic importance of perfusion defects has been clearly established, the meaning of the development and characteristics of electrocardiographic (ECG) changes during dipyridamole infusion is less well defined. This study tries to evaluate the prevalence and significance of ECG changes after dipyridamole infusion and their relation to ischemia in myocardial perfusion single-photon emission computed tomography (SPECT). METHODS: Two hundred patients underwent 2-day dipyridamole stress/rest Tc-99m-sestamibi myocardial perfusion SPECT. Basal and post dipyridamole ECGs were analyzed. Myocardial perfusion images were interpreted visually and semiquantitatively. RESULTS: New ECG changes were noted in 20.2% of cases and consisted of 1.1% T-wave flattening, 1.1% T-wave inversion and 14.8% ST depression and 4.2% psuedonormalization. Abnormal ECG changes were noted after dipyridamole infusion in approximately 27.7% of patients with and 14.3% of patients without reversible defect in myocardial perfusion SPECT. A new ST depression was noted in lateral leads in 72.2% of new ST changes. The mean post-dipyridamole heart rate increment in patients with reversible or partially reversible defects was significantly lesser than in patients with normal myocardial perfusion SPECT. In addition, the corrected QT interval (QTc) increment in patients with reversible defects was significantly more than in patients with fixed defects; however, there was no difference when compared with patients with no defects. Using linear regression model, the severity of ST depression and QTc increment were significant predictors of summed difference score. Sensitivity, specificity, and negative and positive predictive values of ST-segment depression for the diagnosis of ischemia were 20.2, 89.5, 60.7, and 58.4%, respectively. CONCLUSION: The most common ECG change seen after dipyridamole infusion is ST-segment depression. The new ST-segment depression after dipyridamole infusion is highly specific for ischemia. Reversible defects are associated with a lesser increment in heart rate, whereas QTc increment and severity of ST segment depression were significant predictors of summed difference score.
Authors:
Seyed Rasoul Zakavi; Mehdi Taherpour; Fahimesadat Saleh; Ramin Sadeghi; Vahid Reza Dabbagh Kakhki
Related Documents :
8721648 - Clinical use of posterior electrocardiographic leads: a prospective electrocardiographi...
2040318 - St-segment analysis: a useful marker for reperfusion after thrombolysis with apsac? the...
2118828 - Coronary angiographic features within 48 hours from onset of non-q wave myocardial infa...
12538368 - Dynamic qrs-complex and st-segment monitoring by continuous vectorcardiography during c...
18366308 - B-type natriuretic peptides: prognostic markers in stable coronary artery disease.
10634818 - C-reactive protein in offspring is associated with the occurrence of myocardial infarct...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nuclear medicine communications     Volume:  31     ISSN:  1473-5628     ISO Abbreviation:  Nucl Med Commun     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-04-26     Completed Date:  2010-08-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8201017     Medline TA:  Nucl Med Commun     Country:  England    
Other Details:
Languages:  eng     Pagination:  502-5     Citation Subset:  IM    
Affiliation:
Nuclear Medicine Research Center, Emam Reza Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Dipyridamole / administration & dosage*,  adverse effects
Electrocardiography*
Female
Humans
Infusion Pumps*
Ischemia / chemically induced,  physiopathology,  radionuclide imaging
Male
Middle Aged
Myocardial Perfusion Imaging*
Tomography, Emission-Computed, Single-Photon
Chemical
Reg. No./Substance:
58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gene expression and 18FDG uptake in atherosclerotic carotid plaques.
Next Document:  Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with...